(Boursier.com) — Bastide Le Confort Medical fell by 5.2% to 16.8 euros and brought its losses since January 1 to more than 35%. At the end of its first fiscal half-year, management expressed confidence in the continuation of its growth trajectory and confirmed its objectives of an annual turnover of around 530 ME at constant scope and a margin current operational at least equal to that achieved for the 2022-2023 financial year, i.e. 8.4%.
Portzamparc explains that improving the mix makes it possible to increase the gross margin and mitigate salary inflation on the Ebitda margin. The brokerage house maintains its scenario, knowing that the increase in volumes in the second part of the financial year should offset the increase in personnel costs recorded in the first half. The broker reiterates its ‘buy’ opinion but reduces its target from 37 to 30 euros after updating the market parameters.
©2024 Boursier.com